Viewing Study NCT05137795


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2026-04-15 @ 5:08 PM
Study NCT ID: NCT05137795
Status: WITHDRAWN
Last Update Posted: 2023-02-03
First Post: 2021-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19
Sponsor: APR Applied Pharma Research s.a.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module